Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report

BACKGROUND: Moxifloxacin is a fourth-generation fluoroquinolone used as a second-line treatment for multiple bacterial infections. Uveitis has been described as an adverse effect related to this medication. Although several case reports have been published describing uveitis and bilateral acute iris...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Valdivia, Nicolás, Arteaga-Rivera, Karla, Reyes-Guanes, Juliana, Neira-Segura, Natalia, de-la-Torre, Alejandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449864/
https://www.ncbi.nlm.nih.gov/pubmed/34537056
http://dx.doi.org/10.1186/s13256-021-03075-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449864/
https://www.ncbi.nlm.nih.gov/pubmed/34537056
http://dx.doi.org/10.1186/s13256-021-03075-y

Ejemplares similares